---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-062946"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2022-05-19T23:59:59+00:00"
generated_at: "2026-06-25T09:21:10.345507+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Elanco shareholders approve ESPP, eliminate supermajority voting; director elected despite majority against

## Summary
- Shareholders approved elimination of supermajority vote to remove directors, replaced with majority vote.
- Approved Employee Stock Purchase Plan reserving 625,000 shares for employees.
- Charter amendments to remove legacy parent provisions passed with 99.98% votes in favor.
- Director Kapila Kapur Anand elected despite 50.1% against votes; other nominees received >86% support.
- All six proposals passed at May 18, 2022 annual meeting; Ernst & Young ratified as auditor.

## SEC filing metadata
- accession: 0001104659-22-062946
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2022-05-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000110465922062946/0001104659-22-062946-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000110465922062946/tm2215951d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-062946
- JSON: https://secwatch.observer/filing/0001104659-22-062946.json
- Plain text: https://secwatch.observer/filing/0001104659-22-062946.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.